POCI vs. TELA, SRTS, ECOR, FONR, GUTS, LNSR, MLSS, MGRM, EDAP, and HYPR
Should you be buying Precision Optics stock or one of its competitors? The main competitors of Precision Optics include TELA Bio (TELA), Sensus Healthcare (SRTS), electroCore (ECOR), FONAR (FONR), Fractyl Health (GUTS), LENSAR (LNSR), Milestone Scientific (MLSS), Monogram Orthopaedics (MGRM), Edap Tms (EDAP), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.
Precision Optics vs.
Precision Optics (NASDAQ:POCI) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking and institutional ownership.
TELA Bio has a consensus target price of $9.25, indicating a potential upside of 243.87%. Given TELA Bio's stronger consensus rating and higher probable upside, analysts clearly believe TELA Bio is more favorable than Precision Optics.
TELA Bio received 59 more outperform votes than Precision Optics when rated by MarketBeat users. Likewise, 74.68% of users gave TELA Bio an outperform vote while only 0.00% of users gave Precision Optics an outperform vote.
Precision Optics has a beta of 0.27, meaning that its share price is 73% less volatile than the S&P 500. Comparatively, TELA Bio has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.
In the previous week, Precision Optics had 3 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for Precision Optics and 0 mentions for TELA Bio. TELA Bio's average media sentiment score of 0.00 beat Precision Optics' score of -0.19 indicating that TELA Bio is being referred to more favorably in the news media.
Precision Optics has a net margin of -20.01% compared to TELA Bio's net margin of -60.49%. Precision Optics' return on equity of -35.51% beat TELA Bio's return on equity.
13.7% of Precision Optics shares are held by institutional investors. Comparatively, 94.4% of TELA Bio shares are held by institutional investors. 16.3% of Precision Optics shares are held by company insiders. Comparatively, 6.0% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Precision Optics has higher earnings, but lower revenue than TELA Bio. Precision Optics is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.
Summary
TELA Bio beats Precision Optics on 11 of the 18 factors compared between the two stocks.
Get Precision Optics News Delivered to You Automatically
Sign up to receive the latest news and ratings for POCI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Precision Optics Competitors List
Related Companies and Tools
This page (NASDAQ:POCI) was last updated on 1/19/2025 by MarketBeat.com Staff
Free POCI Stock Alerts